Al Schroeder

Al Schroeder is the Co-Founder & Director of R&D at Eikonizo Therapeutics. AI has 15 years of experience in HDAC inhibitors for brain diseases and is the Co-inventor of first-in-class HDAC neuroimaging tool. Previously, Al was a Research Scientist at J.M.Hooker Lab, Martinos Center for Biomedical Imaging.

Al earned his Ph.D. in Biomedical Science, Neuroscience from the University of Massachusetts Medical School in 2008.